Demo Data from EDBT 2026 / reviewers in the wild / expert
Alexander Braunstein
dblp:44/2381
· DBLP profile ↗
1ranked-venue papers
1as first author
0since 2021 · last 2008
—ORCID · none
Domains — the database's venue-derived domains; a paper can count in several
Artificial intelligence and machine learning · 1 · 1 first-author
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 4 heaviest of 5, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › population genetics › coalescent theory
coalescent model |
0.1 | 1 | 2008 | A spatially varying two-sample recombinant coalescent, with applications to HIV escape response · NIPS 2008 |
Bioinformatics and computational biology
phylogenetics |
0.1 | 1 | 2008 | A spatially varying two-sample recombinant coalescent, with applications to HIV escape response · NIPS 2008 |
Bioinformatics and computational biology › population genetics
recombination |
0.1 | 1 | 2008 | A spatially varying two-sample recombinant coalescent, with applications to HIV escape response · NIPS 2008 |
Bioinformatics and computational biology › molecular evolution
viral evolution |
0.1 | 1 | 2008 | A spatially varying two-sample recombinant coalescent, with applications to HIV escape response · NIPS 2008 |
Methods — techniques the papers use, named apart from their topics
hierarchical bayesian model · 0.1
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2008 | A spatially varying two-sample recombinant coalescent, with applications to HIV escape responseabstractStatistical evolutionary models provide an important mechanism for describing and understanding the escape response of a viral population under a particular therapy. We present a new hierarchical model that incorporates spatially varying mutation and recombination rates at the nucleotide level. It also maintains sep- arate parameters for treatment and control groups, which allows us to estimate treatment effects explicitly. We use the model to investigate the sequence evolu- tion of HIV populations exposed to a recently developed antisense gene therapy, as well as a more conventional drug therapy. The detection of biologically rele- vant and plausible signals in both therapy studies demonstrates the effectiveness of the method. Alexander Braunstein, Zhi Wei 0001, Shane T. Jensen, Jon D. McAuliffe |
NIPS | 1 |